Amyloid beta (ABeta) and tau protein are both implicated in memory impairment in early Alzheimer’s disease, but whether and how they interact to cause synaptic dysfunction are unknown. Consequently, I firstly investigated whether tau protein is required for the robust phenomenon of ABeta-induced impairment of hippocampal long-term potentiation (LTP), a widely accepted cellular model of memory. I demonstrate that the absence of tau prevents the ABeta-induced impairment of LTP; moreover, a specific inhibitor of the tau kinase glycogen synthase kinase 3 blocks both an ABeta-induced increase in tau phosphorylation and the ABeta-induced LTP impairment. Thus, tau protein, likely in its phosphorylated form, is required for ABeta to impair LTP. Sec...
Alzheimer's disease (AD) is a highly common neurodegenerative disorder, for which no disease-modifyi...
Summary Enrico Faldini ‘Studies in hippocampal synaptic plasticity: a new protocol for depotentiat...
Alzheimer's disease (AD) is a consequence of degenerative brain pathology with amyloid plaque deposi...
Amyloid beta (ABeta) and tau protein are both implicated in memory impairment in early Alzheimer’s d...
Amyloid β (Aβ) and tau protein are both implicated in memory impairment, mild cognitive impairment (...
Amyloid-beta (Aβ) and tau protein are both involved in the pathogenesis of Alzheimer’s disease. Aβ p...
All synapses are not the same. They differ in their morphology, molecular constituents, and malleabi...
Left-right asymmetries have likely evolved to make optimal use of bilaterian nervous systems; howeve...
Left-right asymmetries have likely evolved to make optimal use of bilaterian nervous systems; howeve...
Left–right asymmetries have likely evolved to make optimal use of bilaterian nervous systems; howeve...
Alzheimer s Disease (AD) is the most common subtype of dementia, first studied by Alois Alzheimer an...
Various animal models of Alzheimer disease (AD) are characterized by deficits in spatial memory that...
Hyperphosphorylation of microtubulin-associated protein tau results in neurofibrillary tangles in cen...
Neuropathological hallmarks of Alzheimer’s disease (AD) include brain β-amyloid deposition and neuro...
Neurofibrillary lesions of abnormal Tau are hallmarks of Alzheimer disease and frontotemporal dement...
Alzheimer's disease (AD) is a highly common neurodegenerative disorder, for which no disease-modifyi...
Summary Enrico Faldini ‘Studies in hippocampal synaptic plasticity: a new protocol for depotentiat...
Alzheimer's disease (AD) is a consequence of degenerative brain pathology with amyloid plaque deposi...
Amyloid beta (ABeta) and tau protein are both implicated in memory impairment in early Alzheimer’s d...
Amyloid β (Aβ) and tau protein are both implicated in memory impairment, mild cognitive impairment (...
Amyloid-beta (Aβ) and tau protein are both involved in the pathogenesis of Alzheimer’s disease. Aβ p...
All synapses are not the same. They differ in their morphology, molecular constituents, and malleabi...
Left-right asymmetries have likely evolved to make optimal use of bilaterian nervous systems; howeve...
Left-right asymmetries have likely evolved to make optimal use of bilaterian nervous systems; howeve...
Left–right asymmetries have likely evolved to make optimal use of bilaterian nervous systems; howeve...
Alzheimer s Disease (AD) is the most common subtype of dementia, first studied by Alois Alzheimer an...
Various animal models of Alzheimer disease (AD) are characterized by deficits in spatial memory that...
Hyperphosphorylation of microtubulin-associated protein tau results in neurofibrillary tangles in cen...
Neuropathological hallmarks of Alzheimer’s disease (AD) include brain β-amyloid deposition and neuro...
Neurofibrillary lesions of abnormal Tau are hallmarks of Alzheimer disease and frontotemporal dement...
Alzheimer's disease (AD) is a highly common neurodegenerative disorder, for which no disease-modifyi...
Summary Enrico Faldini ‘Studies in hippocampal synaptic plasticity: a new protocol for depotentiat...
Alzheimer's disease (AD) is a consequence of degenerative brain pathology with amyloid plaque deposi...